2026 Q3 Portfolio Activity
In 2026 Q3, Crestline Management, L.P. maintained a portfolio of 3 distinct positions. Conversely, Crestline Management, L.P. completely exited their position in 8X8 INC NEW.
Position History
hover any row below to update
Loading…
Total Positions
3
Quarter
2026 Q3
Top Holding
DNLI (92.5%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-3 of 3
Crestline Management, L.P. Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNLI
DENALI THERAPEU...
|
Healthcare | 92.48% | 91.74% |
#1
Prev: #1
|
6.0 |
—
|
-900,000 | -40.7% |
P
S
|
1,310,732 | $27,092,830 |
$33.41
-46.1%
|
2017 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
SANA
SANA BIOTECHNOL...
|
Healthcare | 7.52% | 4.70% |
#2
Prev: #2
|
5.5 |
—
|
no change | no change |
P
S
|
755,736 | $2,202,970 |
$18.48
-89.8%
|
2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | ||
|
EGHT
8X8 INC NEW
|
Technology | 0.00% | 3.56% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-990,850 | -100.0% |
CLOSED
|
— | $— |
$6.77
-68.1%
|
2016 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-3 of 3 holdings